317 related articles for article (PubMed ID: 18836996)
1. Comparative epigenomics of human and mouse mammary tumors.
Demircan B; Dyer LM; Gerace M; Lobenhofer EK; Robertson KD; Brown KD
Genes Chromosomes Cancer; 2009 Jan; 48(1):83-97. PubMed ID: 18836996
[TBL] [Abstract][Full Text] [Related]
2. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer.
Cameron EE; Bachman KE; Myöhänen S; Herman JG; Baylin SB
Nat Genet; 1999 Jan; 21(1):103-7. PubMed ID: 9916800
[TBL] [Abstract][Full Text] [Related]
3. Methylation silencing of angiopoietin-like 4 in rat and human mammary carcinomas.
Hattori N; Okochi-Takada E; Kikuyama M; Wakabayashi M; Yamashita S; Ushijima T
Cancer Sci; 2011 Jul; 102(7):1337-43. PubMed ID: 21489049
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.
Ai L; Tao Q; Zhong S; Fields CR; Kim WJ; Lee MW; Cui Y; Brown KD; Robertson KD
Carcinogenesis; 2006 Jul; 27(7):1341-8. PubMed ID: 16501252
[TBL] [Abstract][Full Text] [Related]
5. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma.
Wong CM; Ng YL; Lee JM; Wong CC; Cheung OF; Chan CY; Tung EK; Ching YP; Ng IO
Hepatology; 2007 May; 45(5):1129-38. PubMed ID: 17464989
[TBL] [Abstract][Full Text] [Related]
6. Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs.
Deng G; Kakar S; Okudiara K; Choi E; Sleisenger MH; Kim YS
Clin Cancer Res; 2009 Mar; 15(5):1519-26. PubMed ID: 19223499
[TBL] [Abstract][Full Text] [Related]
7. Evidence of epigenetic regulation of the tumor suppressor gene cluster flanking RASSF1 in breast cancer cell lines.
da Costa Prando E; Cavalli LR; Rainho CA
Epigenetics; 2011 Dec; 6(12):1413-24. PubMed ID: 22139571
[TBL] [Abstract][Full Text] [Related]
8. Interaction of 5-aza-2'-deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3sigma, E-cadherin and tissue inhibitor of metalloproteinase 3 expression in human breast carcinoma cells.
Gagnon J; Shaker S; Primeau M; Hurtubise A; Momparler RL
Anticancer Drugs; 2003 Mar; 14(3):193-202. PubMed ID: 12634613
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells.
Heller G; Schmidt WM; Ziegler B; Holzer S; Müllauer L; Bilban M; Zielinski CC; Drach J; Zöchbauer-Müller S
Cancer Res; 2008 Jan; 68(1):44-54. PubMed ID: 18172295
[TBL] [Abstract][Full Text] [Related]
10. Prolonged re-expression of the hypermethylated gene EPB41L3 using artificial transcription factors and epigenetic drugs.
Huisman C; van der Wijst MG; Falahi F; Overkamp J; Karsten G; Terpstra MM; Kok K; van der Zee AG; Schuuring E; Wisman GB; Rots MG
Epigenetics; 2015; 10(5):384-96. PubMed ID: 25830725
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma.
Foltz G; Ryu GY; Yoon JG; Nelson T; Fahey J; Frakes A; Lee H; Field L; Zander K; Sibenaller Z; Ryken TC; Vibhakar R; Hood L; Madan A
Cancer Res; 2006 Jul; 66(13):6665-74. PubMed ID: 16818640
[TBL] [Abstract][Full Text] [Related]
12. Identification of epigenetically silenced genes in tumor endothelial cells.
Hellebrekers DM; Melotte V; Viré E; Langenkamp E; Molema G; Fuks F; Herman JG; Van Criekinge W; Griffioen AW; van Engeland M
Cancer Res; 2007 May; 67(9):4138-48. PubMed ID: 17483324
[TBL] [Abstract][Full Text] [Related]
13. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
Lee SH; Kim J; Kim WH; Lee YM
Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
[TBL] [Abstract][Full Text] [Related]
14. LRRC3B, encoding a leucine-rich repeat-containing protein, is a putative tumor suppressor gene in gastric cancer.
Kim M; Kim JH; Jang HR; Kim HM; Lee CW; Noh SM; Song KS; Cho JS; Jeong HY; Hahn Y; Yeom YI; Yoo HS; Kim YS
Cancer Res; 2008 Sep; 68(17):7147-55. PubMed ID: 18757430
[TBL] [Abstract][Full Text] [Related]
15. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
Magdinier F; Wolffe AP
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of protein phosphatase 2A (PP2A), lymphotactin (XCL1) and estrogen receptor alpha (ER) expression in human breast cancer cells.
Keen JC; Garrett-Mayer E; Pettit C; Mack KM; Manning J; Herman JG; Davidson NE
Cancer Biol Ther; 2004 Dec; 3(12):1304-12. PubMed ID: 15662126
[TBL] [Abstract][Full Text] [Related]
17. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21.
Derks S; Bosch LJ; Niessen HE; Moerkerk PT; van den Bosch SM; Carvalho B; Mongera S; Voncken JW; Meijer GA; de Bruïne AP; Herman JG; van Engeland M
Carcinogenesis; 2009 Jun; 30(6):1041-8. PubMed ID: 19329758
[TBL] [Abstract][Full Text] [Related]
18. Synergistic antineoplastic action of DNA methylation inhibitor 5-AZA-2'-deoxycytidine and histone deacetylase inhibitor depsipeptide on human breast carcinoma cells.
Primeau M; Gagnon J; Momparler RL
Int J Cancer; 2003 Jan; 103(2):177-84. PubMed ID: 12455031
[TBL] [Abstract][Full Text] [Related]
19. Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation.
Zhang YW; Staal B; Dykema KJ; Furge KA; Vande Woude GF
PLoS One; 2012; 7(6):e38955. PubMed ID: 22701735
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity.
Cantor JP; Iliopoulos D; Rao AS; Druck T; Semba S; Han SY; McCorkell KA; Lakshman TV; Collins JE; Wachsberger P; Friedberg JS; Huebner K
Int J Cancer; 2007 Jan; 120(1):24-31. PubMed ID: 17019711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
